New cancer clinical trial: Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer

Published on: October 30, 2018 at 09:30PM

• Tweet
• Share
• Share
• Share
• Share